Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emergency Use of Voriconazole in Patients With Life Threatening, Invasive Mycoses
NCT00015665Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of voriconazole in mycosis, sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2001; status: completed.
02
Drugs
voriconazole
03
Conditions
mycosis
Beyond the preview
Go deeper on NCT00015665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015665.